Back to top

Analyst Blog

Integra LifeSciences Holdings Corporation (IART - Analyst Report) announced the first human implantation of its U.S. Food and Drug Administration (FDA) approved Integra Laminoplasty System in the U.S. The system is designed for treating patients with ossification of the posterior longitudinal ligament, cervical myelopathy and degenerative spinal canal stenos.

The Laminoplasty System is composed of a wide range of robust, arched plate designs, self-drilling bone screws and multiple insertion options. The system proved itself to be user friendly during the implantation procedure. The arched radius of the plate allows for spinal canal expansion. Moreover, the foot on the plate provides efficient initial stability.

The Laminoplasty System is a part of Integra’s Spine segment which accounted for 21.5% of the company’s total revenue in 2013. In a bid to strengthen this segments offering, Integra introduced the FDA approved Integra Hollywood NanoMetalene Interbody Device (IBD). The IBD is used primarily in transforaminal lumbar interbody fusion (TLIF).

Integra has strengthened its claim for the leadership position in the global laminoplasty market which is estimated to reach approximately $70 million by 2015. However, we would like to remain on the sidelines at present unless some visibility is gained regarding the acceptability and performance of Integra’s Laminoplasty system in the market.

Integra currently bears a Zacks Rank #3 (Hold). Some better-ranked stocks worth considering in the overall medical sector are Alexion Pharmaceuticals, Inc. (ALXN), Alkermes plc (ALKS - Analyst Report) and ANI Pharmaceuticals, Inc. (ANIP - Snapshot Report). All these stocks carry a Zacks Rank #1 (Strong Buy).

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
UNITED THER… UTHR 117.83 +28.51%
TRIQUINT SE… TQNT 20.67 +6.52%
RF MICRO DE… RFMD 12.47 +6.04%
VASCO DATA… VDSI 14.77 +4.68%
BANCO DO BR… BDORY 15.53 +3.95%